Cancer Research Institute (CRI) Clinical Innovator Program 2026 (With Funding Available)

Get latest opportunities sent your Inbox

---

Join our Telegram Channel Follow us on WhatsApp

About CRI Clinical Innovator Program

The CRI Clinical Innovator Program is a research funding opportunity for investigators developing innovative clinical trials that could advance cancer immunotherapy and improve treatment options for patients.The programme focuses on studies that combine clinical investigation with a deeper understanding of how the immune system responds to cancer treatment.

• Sponsor Organisation: Cancer Research Institute (CRI)

Benefits of CRI Clinical Innovator Program

The CRI Clinical Innovator Program provides:

• Up to $1,000,000 per clinical trial
• Up to 10% indirect costs in addition to the awarded funds

The grant is intended to provide the resources necessary to conduct the proposed clinical investigation.

CRI Clinical Innovator Program Requirements

The programme is intended for academic researchers and clinician-scientists leading investigator-initiated clinical trials.

Applicants must:

• Serve as the Principal Investigator (PI) of the proposed study.
• Develop an investigator-initiated immunotherapy clinical trial.
• Conduct an eligible Phase I/II or Phase II study.
• Have an appropriate medical or research institution capable of conducting the proposed trial.

There are no citizenship restrictions.

Application Date and Process

• Click on the link to the application website to apply.

Application Deadline

01 December, 2026

Opportunity Application

View details of CRI Clinical Innovator Program

Apply for CRI Clinical Innovator Program